Comorbidities and the Effect of Comorbidities on Recurrence in Benign Paroxysmal Positional Vertigo

Yıl 2022, Cilt: 4 Sayı: 3, 405 - 409, 22.09.2022

Nur Dilara Çetinkaya , Süha Ertuğrul , Emre Söylemez , Didem Sunay

https://doi.org/10.37990/medr.1108147

Öz

Aim: Our study aims to investigate comorbidities and the effect of comorbidities on recurrence in posterior canal benign paroxysmal positional vertigo (P-BPPV).
Materials and Methods: Fifty-four patients diagnosed with P-BPPV were included in the study. Demographic characteristics of the patients, smoking, alcohol use, P-BPPV side, comorbid diseases, menopausal status, previous head trauma history, body mass index (BMI) and biochemical parameter results were recorded. Reposition maneuver (Epley) was applied to the patients, and the patients were followed up for six months. Fifty-four patients followed were divided into two groups according to P-BPPV recurrence. Twenty-three patients with relapsed P-BPPV were included in group I, and 31 patients with non-relapsed BPPV were included in group II.
Results: There was no difference between the two groups in terms of age, comorbid diseases, menopausal status, gender, BMI, smoking, alcohol use and biochemical parameters (p>0.05). The recurrence rate was lower in P-BPPV patients with right ear involvement (p<0.05).
Conclusions: Recurrence is observed less frequently in individuals with P-BPPV whose right ear is affected than in those whose left ear is affected. Our study shows that P-BPPV, comorbid diseases and abnormal biochemical parameters, which are more common in advancing ages, are observed together coincidentally.

Anahtar Kelimeler

BPPV, Vertigo, Relapse, Comorbid diseases, biochemical parameters

Benign Paroksismal Pozisyonel Vertigoda Komorbiditeler ve Komorbiditelerin Rekürrens Üzerine Etkisi

Öz

Amaç: Çalışmamızın amacı, posterior kanal benign paroksismal pozisyonel vertigoda (P-BPPV) komorbiditeleri ve komorbiditelerin nüks üzerindeki etkisini araştırmaktır.
Materyal ve Metot: P-BPPV tanısı alan 54 hasta çalışmaya dahil edildi. Hastaların demografik özellikleri, sigara ve alkol kullanımı, P-BPPV tarafı, komorbid hastalıkları, menapoz durumu, geçirilmiş kafa travması öyküsü, vücut kitle indeksi (BMI) ve biyokimyasal parametre sonuçları kaydedildi. Hastalara repozisyon manevrası (Epley) uygulandı ve hastalar altı ay takip edildi. Takip edilen 54 hasta nüks etme durumuna göre iki gruba ayrıldı. P-BPPV’si nüks eden 23 hasta grup I’e BPPV’si nüks etmeyen 31 hasta grup II’ye dahil edildi.
Bulgular: İki grup arasında yaş, komorbid hastalıklar, cinsiyet, menapoz durumu, BMI, sigara, alkol kullanımı ve biyokimyasal parametreler açısından bir fark yoktu (p>0.05). Sağ kulağı tutulan P-BPPV hastalarında nüks oranının daha az olduğu saptandı (p<0.05).
Sonuçlar: Sağ kulağı etkilenen BPPV’li bireylerde nüks, sol kulağı etkilenen P-BPPV’li bireylere göre daha az gözlenmektedir. Çalışmamızdan ilerleyen yaşlarda daha sık görülen P-BPPV, komorbid hastalıklar ve anormal biyokimyasal parametrelerin tesadüf olarak birlikte gözlendiği çıkarılabilir.

Anahtar Kelimeler

Benign paroksismal pozisyonel vertigo, vertigo, nüks, komorbid hastalıklar, biyokimyasal parametreler

Kaynakça

• Thompson TL, Amedee R. Vertigo: a review of common peripheral and central vestibular disorders. Ochsner J. 2009;9(1):20-6.
• Güneri EA. Benign paroksismal pozisyonel baş dönmesinde tanı ve tedavi algoritması. Türkiye Klinikleri J E.N.T.-Special Topics. 2013;6:89-95.
• Babac S, Djeric D, Petrovic-Lazic M, et al. Why do treatment failure and recurrences of benign paroxysmal positional vertigo occur? Otol Neurotol. 2014;35:1105-10.
• Chen J, Zhang S, Cui K, Liu C. Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis. J Neurol. 2021;268(11):4117-27.
• Li S, Wang Z, Liu Y, et al. Risk Factors for the Recurrence of Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis. Ear Nose Throat J. 2022;101(3):112-34.
• Büki B, Ecker M, Jünger H, Lundberg YW. Vitamin D deficiency and benign paroxysmal positioning vertigo. Med Hypotheses. 2013;80(2):201-4.
• Akkoca Ö, Tüzüner A, Ersöz Ünlü C, et al.The Effects of Systemic Disease on the Benign Paroxismal Positional Vertigo Attacks. Journal of Ankara University Faculty of Medicine. 2018;71(2):170-3.
• Dağkıran M, Sürmelioğlu Ö, Ay Ö. Diagnosis and Treatment Approach in Benign ParoxysmalPositional Vertigo. Arşiv Kaynak Tarama Dergisi. 2015;24(4):555-64.
• Steenerson RL, Cronin GW, Marbach PM. Effectiveness of treatment techniques in 923 cases of benign paroxysmal positional vertigo. Laryngoscope. 2005;115(2):226-31.
• Brandt T, Huppert D, Hecht J, et al. Benign paroxysmal positioning vertigo: a long-term follow-up (6-17 years) of 125 patients. Acta Otolaryngol. 2006;126(2):160-3.
• Kansu L, Avci S, Yilmaz I, Ozluoglu LN. Long-term follow-up of patients with posterior canal benign paroxysmal positional vertigo. Acta Otolaryngol. 2010;130(9):1009-12.
• Ahn SK, Jeon SY, Kim JP, el al. Clinical characteristics and treatment of benign paroxysmal positional vertigo after traumatic brain injury. J Trauma. 2011;70(2):442-6.
• Picciotti PM, Lucidi D, De Corso E, et al. Comorbidities and recurrence of benign paroxysmal positional vertigo: personal experience. Int J Audiol. 2016;55(5):279-84.
• Batuecas-Caletrio A, Trinidad-Ruiz G, Zschaeck C, et al. Benign paroxysmal positional vertigo in the elderly. Gerontology. 2013;59(5):408-12.
• Zhu CT, Zhao XQ, Ju Y, et al. Clinical Characteristics and Risk Factors for the Recurrence of Benign Paroxysmal Positional Vertigo. Front Neurol. 2019;13;10:1190.
• Pérez P, Franco V, Cuesta P, et al. Recurrence of benign paroxysmal positional vertigo. Otol Neurotol. 2012;33(3):437-43.
• Cakir BO, Ercan I, Cakir ZA, et al. Relationship between the affected ear in benign paroxysmal positional vertigo and habitual head-lying side during bedrest. J Laryngol Otol. 2006;120(7):534-6.
• Singh JM, Corser WD, Monsell EM. Cardiovascular Risk Factors and Benign Paroxysmal Positional Vertigo in Community Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg. 2020;162(3):283-9.
• De Stefano A, Dispenza F, Suarez H, et al. A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx. 2014;41(1):31-6.
• Sunami K, Tochino R, Tokuhara Y, et al. Effects of cigarettes and alcohol consumption in benign paroxysmal positioning vertigo. Acta Otolaryngol. 2006;126(8):834-8.
• Webster G, Sens PM, Salmito MC, et al. Hyperinsulinemia and hyperglycemia: risk factors for recurrence of benign paroxysmal positional vertigo. Braz J Otorhinolaryngol. 2015;81(4):347-51.
• Yüceant GA. BPPV etyoloji ve rekkürenslerinde bir etken olarak osteoporozun değerlendirilmesi. T.C. Haseki Eğitim ve Araştırma Hastanesi. Uzmanlık Tezi. İstanbul 2015.
• Talaat HS, Abuhadied G, Talaat AS, Abdelaal MS. Low bone mineral density and vitamin D deficiency in patients with benign positional paroxysmal vertigo. Eur Arch Otorhinolaryngol. 2015;272(9):2249-53.
• Yang B, Lu Y, Xing D, et al. Association between serum vitamin D levels and benign paroxysmal positional vertigo: a systematic review and meta-analysis of observational studies. Eur Arch Otorhinolaryngol. 2020;277(1):169-177.
• Ogun OA, Büki B, Cohn ES, et al. Menopause and benign paroxysmal positional vertigo. Menopause. 2014;21(8):886-9.